S

Sandoz Group AG
SIX:SDZ

Watchlist Manager
Sandoz Group AG
SIX:SDZ
Watchlist
Price: 40.6 CHF 2.4% Market Closed
Market Cap: 17.9B CHF
Have any thoughts about
Sandoz Group AG?
Write Note

Relative Value

The Relative Value of one SDZ stock under the Base Case scenario is 47.39 CHF. Compared to the current market price of 40.6 CHF, Sandoz Group AG is Undervalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SDZ Relative Value
Base Case
47.39 CHF
Undervaluation 14%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
58
Median 3Y
1.5
Median 5Y
1.5
Industry
2.5
Forward
1.9
vs History
6
vs Industry
1
Median 3Y
193.6
Median 5Y
193.6
Industry
21.9
Forward
16
vs History
6
vs Industry
9
Median 3Y
41.2
Median 5Y
41.2
Industry
16.5
vs History
19
vs Industry
34
Median 3Y
4.4
Median 5Y
4.4
Industry
23.6
vs History
6
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.1
vs History
6
vs Industry
57
Median 3Y
1.5
Median 5Y
1.5
Industry
2.6
Forward
2.2
vs History
6
vs Industry
53
Median 3Y
3.2
Median 5Y
3.2
Industry
5.2
vs History
6
vs Industry
35
Median 3Y
8.3
Median 5Y
8.3
Industry
13.3
Forward
11
vs History
6
vs Industry
32
Median 3Y
11.8
Median 5Y
11.8
Industry
16.6
Forward
13.4
vs History
6
vs Industry
9
Median 3Y
41.2
Median 5Y
41.2
Industry
15.6
vs History
vs Industry
Median 3Y
-56.7
Median 5Y
-56.7
Industry
19.1
vs History
6
vs Industry
Median 3Y
0
Median 5Y
0
Industry
1.9

Multiples Across Competitors

SDZ Competitors Multiples
Sandoz Group AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Sandoz Group AG
SIX:SDZ
17.5B CHF 2 253.4 12.8 18.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CH
S
Sandoz Group AG
SIX:SDZ
Average P/E: 60
253.4
2 110%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top